Case Study: a Dubai-based Healthcare Company achieves timely SFDA registration of Paclitaxel with FREYR

a Dubai-based Healthcare Company achieves timely SFDA registration of Paclitaxel with FREYR

A Dubai-based healthcare company sought FREYR's regulatory expertise for the initial SFDA registration of its product, Paclitaxel PhaRes. As a new applicant, the client was unfamiliar with the SFDA’s submission process and faced challenges due to regulatory complexities and strict timelines, which posed a significant risk of delays and non-compliance.

FREYR conducted a gap analysis, compiled the eCTD dossier, and guided the client through the entire submission process. This solution ensured a timely and compliant submission to the SFDA. FREYR's support provided a clear regulatory strategy, minimized compliance risks, and secured the successful registration of the product.